News & Articles

Find out why PROTACs hold such promise in cancer drug discovery

Organoid expert reveals recent developments, benefits, and challenges in organoid research

3D imaging technology provides images of the cell cluster down to the nuclei while mitigating drug discovery risks

Your solution for quick and easy filtration of single-cell suspensions

Discover a comprehensive guide to real-time live-cell imaging and analysis

Development collaboration integrates Sartorius Stedim Biotech’s BIOSTAT® STR bioreactors and Repligen’s XCell™ ATF cell retention control technology

Find out about new tools and techniques to streamline biopharmaceutical analysis

Biotech scientist shares the importance of reliable technologies in the production of therapeutic proteins

Researchers reveal new insights into self repair pathways in cancer cells, after therapy with PARP inhibitors

Discover how scientists in Sweden and Finland are developing a functional systems precision medicine strategy to optimize treatment of acute myeloid leukemia

New 3D model provides options for drug development and treatment of gestational disorders

Dedicated facility developed in response to increasing demand for product development projects in diagnostics, R&D and bioprocess

Discover how 3D models of glioblastoma using patient-derived stem cells could enable more effective treatment

Watch the product launch video for more information

AMSBIO has announced an exosome isolation, manufacturing, and characterization service to enable R&D groups to accelerate their discovery and development activities

SelectScience will be attending the AACC Annual Meeting in Chicago, USA, to interview leading scientists and report on the latest technologies

The findings could help clinicians decide the best course and delivery of treatment for cancer patients

The first chemically-defined, animal component-free cell culture medium for natural killer (NK) cells

Funding announced for the EU research project iConsensus

Algenuity launches multidisciplinary renewables biosynthesis project under Horizon 2020 programme

ScreenIn3D to offer platforms for personalized cancer treatment